Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Shares Outstanding (Weighted Average) (2016 - 2025)

Medifast (MED) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.47% year-over-year to $11.0 million, compared with a TTM value of $11.0 million through Dec 2025, changed 0.47%, and an annual FY2025 reading of $11.0 million, changed 0.47% over the prior year.
  • Shares Outstanding (Weighted Average) was $11.0 million for Q4 2025 at Medifast, roughly flat from $11.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $11.8 million in Q1 2021 and bottomed at $10.9 million in Q1 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $11.2 million, with a median of $11.0 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Weighted Average) decreased 6.0% in 2023, then rose 0.62% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $11.7 million in 2021, then decreased by 4.36% to $11.2 million in 2022, then dropped by 2.78% to $10.9 million in 2023, then grew by 0.42% to $10.9 million in 2024, then increased by 0.47% to $11.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for MED at $11.0 million in Q4 2025, $11.0 million in Q3 2025, and $11.0 million in Q2 2025.